Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3918
Gene Symbol: LAMC2
LAMC2
0.030 Biomarker disease BEFREE He was confirmed neurosyphilis according to the CSF tests for syphilis. 28056870 2017
Entrez Id: 3812
Gene Symbol: KIR3DL2
KIR3DL2
0.010 GeneticVariation disease BEFREE Human leukocyte antigen-C and killer cell immunoglobulin-like receptor gene polymorphisms among patients with syphilis in a Chinese Han population. 22958291 2012
Entrez Id: 3806
Gene Symbol: KIR2DS1
KIR2DS1
0.010 GeneticVariation disease BEFREE Human leukocyte antigen-C and killer cell immunoglobulin-like receptor gene polymorphisms among patients with syphilis in a Chinese Han population. 22958291 2012
Entrez Id: 959
Gene Symbol: CD40LG
CD40LG
0.010 Biomarker disease BEFREE In addition, the sera of patients with positive specific IGM (serologically diagnosed syphilis, asymptomatic state) were also positive in PCR. 10322608 1999
Entrez Id: 3605
Gene Symbol: IL17A
IL17A
0.010 GeneticVariation disease BEFREE In conclusion, the polymorphisms of IL-17A rs2275913 and rs3819024 and the haplotype containing these two SNPs influenced the susceptibility to syphilis in a Han Chinese population. 30171709 2018
Entrez Id: 693155
Gene Symbol: MIR570
MIR570
0.010 Biomarker disease BEFREE In patients with neurosyphilis (NSP), miR-590-5p, miR-570-3p and miR-570-5p were upregulated in the CSF and serum, when compared with patients with syphilis without neurosyphilis (SP). miR-590-5p and miR-570-3p were significantly upregulated (p<0.001). 30926713 2019
Entrez Id: 693175
Gene Symbol: MIR590
MIR590
0.010 Biomarker disease BEFREE In patients with neurosyphilis (NSP), miR-590-5p, miR-570-3p and miR-570-5p were upregulated in the CSF and serum, when compared with patients with syphilis without neurosyphilis (SP). miR-590-5p and miR-570-3p were significantly upregulated (p<0.001). 30926713 2019
Entrez Id: 5422
Gene Symbol: POLA1
POLA1
0.010 Biomarker disease BEFREE In this study, a nested PCR method targeting the Tpp47 and polA genes (Tpp47-Tp-PCR and polA-Tp-PCR) was developed to detect TP-DNA in whole blood samples collected from 262 patients with different stages of syphilis (84 primary syphilis, 97 secondary syphilis, and 81 latent syphilis patients). 29739928 2018
Entrez Id: 1308
Gene Symbol: COL17A1
COL17A1
0.010 Biomarker disease BEFREE Interestingly, reactive syphilis serology in both HIV-infected individuals and uninfected controls was associated with positive anti-BP180 ELISA results (adjusted odds ratio (OR) 2.14, 95% confidence interval (CI) 1.07-4.29, p = 0.03 and OR 4.70, CI 1.3-16.86; p = 0.0180). 31282975 2019
Entrez Id: 3627
Gene Symbol: CXCL10
CXCL10
0.010 Biomarker disease BEFREE Median proportion of PBMCs that were activated monocytes (16.6 vs. 5.3), and median CSF CXCL10 (10658 vs. 2530 units), CCL2 (519 vs. 337 units) and HIV RNA (727 vs. 50 c/mL) were higher in neurosyphilis than in uncomplicated syphilis (P ≤ .001 for all comparisons). 28525592 2017
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.010 Biomarker disease BEFREE Median proportion of PBMCs that were activated monocytes (16.6 vs. 5.3), and median CSF CXCL10 (10658 vs. 2530 units), CCL2 (519 vs. 337 units) and HIV RNA (727 vs. 50 c/mL) were higher in neurosyphilis than in uncomplicated syphilis (P ≤ .001 for all comparisons). 28525592 2017
Entrez Id: 5443
Gene Symbol: POMC
POMC
0.010 GeneticVariation disease BEFREE No potential for syphilis false positive result (no false positive vs. some potential for false positive) had the largest average impact on willingness to use the test and on average accounted for 23.8% of test type preference, followed by cost (free vs. ~USD$4; 21.6%), time to results (20 minutes vs. 1 week; 17.4%), number of blood draws (1 draw vs. 2 draws; 13.8%), method of blood draw (fingerprick vs. venipuncture; 13.7%), and test type (rapid POC vs. laboratory; 9.7%). 30372465 2018
Entrez Id: 2137
Gene Symbol: EXTL3
EXTL3
0.020 Biomarker disease BEFREE Of the 92 discordant samples, 9 were from the baseline visit (RPR-C titre: 1-8), which could have led to possible missed diagnoses using the RPR-S.<b>Conclusions.</b> The sensitivity and accuracy of the RPR-S test requires improvement before it can be used to diagnose syphilis and evaluate treatment efficacy in clinical practice. 28792374 2017
Entrez Id: 5919
Gene Symbol: RARRES2
RARRES2
0.010 Biomarker disease BEFREE Our results highlight the role of Tp0965-induced chemerin in endothelial cells dysfunction, which contributes to the immunopathogenesis of vascular inflammation of syphilis. 31322756 2019
Entrez Id: 340075
Gene Symbol: ARSI
ARSI
0.010 Biomarker disease BEFREE Overall, the fully automated AIX1000 system demonstrated significantly enhanced sensitivity and specificity similar to that of the manual ASI RPR card test, making the AIX1000 system suitable for the laboratory diagnosis of syphilis in a clinical laboratory setting. 29618500 2018
Entrez Id: 181
Gene Symbol: AGRP
AGRP
0.010 Biomarker disease BEFREE Patients diagnosed with syphilis were twice as likely not to be taking ART and had a higher likelihood of having plasma HIV RNA viral loads > 1000 copies/mL (19%). 29534681 2018
Entrez Id: 9048
Gene Symbol: ARTN
ARTN
0.010 Biomarker disease BEFREE Patients diagnosed with syphilis were twice as likely not to be taking ART and had a higher likelihood of having plasma HIV RNA viral loads > 1000 copies/mL (19%). 29534681 2018
Entrez Id: 7096
Gene Symbol: TLR1
TLR1
0.010 GeneticVariation disease BEFREE Polymorphisms in the genes for TLR1 (a T→G mutation at position 1805), TLR2 (a G→A mutation at position 2258), and TLR6 (a C→T mutation at position 745) were sought in 456 white patients with syphilis. 24922103 2014
Entrez Id: 7097
Gene Symbol: TLR2
TLR2
0.010 GeneticVariation disease BEFREE Polymorphisms in the genes for TLR1 (a T→G mutation at position 1805), TLR2 (a G→A mutation at position 2258), and TLR6 (a C→T mutation at position 745) were sought in 456 white patients with syphilis. 24922103 2014
Entrez Id: 10333
Gene Symbol: TLR6
TLR6
0.010 GeneticVariation disease BEFREE Polymorphisms in the genes for TLR1 (a T→G mutation at position 1805), TLR2 (a G→A mutation at position 2258), and TLR6 (a C→T mutation at position 745) were sought in 456 white patients with syphilis. 24922103 2014
Entrez Id: 5340
Gene Symbol: PLG
PLG
0.010 GeneticVariation disease BEFREE Positive syphilis serology (rapid plasmin reagin) was found in 29%-31% of HIV+ FSWs and 9%-12% of HIV- FSWs and SMs. 31204869 2019
Entrez Id: 64137
Gene Symbol: ABCG4
ABCG4
0.010 Biomarker disease BEFREE Previously, we determined the crystal structure of apo-TpMglB-2, a d-glucose-binding component of a putative ABC transporter from the syphilis spirochete Treponema pallidum. 29318719 2018
Entrez Id: 25842
Gene Symbol: ASF1A
ASF1A
0.010 Biomarker disease BEFREE Quebec's laboratory network previously showed that 3.3% of EIA/CIA reactive and weakly-reactive RPR samples (RPR titer of 1 to 4) would have been misclassified as syphilis cases if a treponemal confirmatory test had not been performed. 30212544 2018
Entrez Id: 57727
Gene Symbol: NCOA5
NCOA5
0.010 Biomarker disease BEFREE Quebec's laboratory network previously showed that 3.3% of EIA/CIA reactive and weakly-reactive RPR samples (RPR titer of 1 to 4) would have been misclassified as syphilis cases if a treponemal confirmatory test had not been performed. 30212544 2018
Entrez Id: 5447
Gene Symbol: POR
POR
0.010 Biomarker disease BEFREE Relative to men who had ever tested for both infections, those with increased probability of never testing for HIV/syphilis include non-gay sexual identity (prevalence odds ratio [POR] 1.86; 95% confidence interval [CI], 1.45-2.37), not disclosed their sexuality/sexual history with men other than their regular partner (POR, 2.22; 95% CI, 1.75-2.78]) or with health professionals (POR, 11.11; 95% CI, 7.69-14.29), no condomless sex with casual partners in the last 3 months (POR, 1.89; 95% CI, 1.37-2.56), no community engagement in sexual health (POR, 15.16; 95% CI, 9.40-24.45), and mainly met partners offline (POR, 1.49; 95% CI, 1.16-1.92). 29750773 2018